Gender-neutral vaccination of children, aged 11-12, has been proven effective in preventing HPV and related cancers, including oropharyngeal, cervical, anal, vulvar, penile, and vaginal cancers.
The U.S. Healthy People 2020 goal is for 93 percent of females between the ages of 21 and 65 to be screened for cervical cancer; however, only 80 percent of eligible women currently follow this recommendation.
Recommendations from trusted health care providers are one of the most effective interventions for preventing HPV infection and HPV-related cancers.